Viewing Study NCT00515203

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:46 PM
Ignite Modification Date: 2026-02-02 @ 6:35 PM
Study NCT ID: NCT00515203
Status: COMPLETED
Last Update Posted: 2014-07-25
First Post: 2007-08-09
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects
Sponsor: Amgen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Idiopathic Thrombocytopenic Purpura View
None Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) View
None Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immune (Idiopathic) Thrombocytopenic Purpura View
None Pediatric Idiopathic Thrombocytopenic Purpura View